This text is a result of machine translation.
Cro plate fell, and Wuxi apptec fell nearly 10%
Baidu responded that it was unable to search "referee document network": caused by misoperation of the technical team
CHAGEE Eyes U.S. IPO Amid Go-Global Push
In 2023, CHAGEE expanded with over 2,000 new stores, and plans to open another thousand this year. In April, they signed tennis star Zheng Qinwen, successfully leveraging a crucial Olympic marketing window. CHAGEE has quickly become the "lucky star" of the tea beverage industry, capturing everyone’s attention.
Sep 29, 2024 12:51 PM
CRO ClinChoice Raises USD 150 Mn in Series E Round
2015 is the inflection point for the development of China's innovative drug industry and CRO (clinical research organization). On July 22nd, 2015, after CDE (Center For Drug Evaluation) released the announcement on self-examination and verification of drug clinical trial data, the supervision of Chinese clinical trials moved towards standardization. The investment and financing of innovative drugs in China continued to increase, laying the foundation for the growth of CRO.
Jul 05, 2022 08:17 PM
WuXi AppTec: A Favorable Chinese Stock for MSCI and FTSE Russell
According to the latest quarterly index review, a Wuxi-based CRO company will be incorporated into the FTSE China A 50 Share Index. It has been considered a top holding by many MSCI China indexes for some time.
Jun 08, 2020 09:51 AM
Cro stocks rose in early trading
360 Billion: How Can Chinese Companies Grow Together with Africa
Sep 27, 2024 06:30 PM